Close
Xylem
Thermofisher
News

Teva Completes Acquisition of Theramex

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Drug Research

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.
Drug Research

EMA Initiates Data Sharing Pilot for New Approach Methodologies

The European Medicines Agency has launched a voluntary framework for sharing data from non-animal testing methods to build regulatory confidence and refine drug development.
Business & Industry

Novartis Signs $3.22 Billion Deal with Alteogen for Subcutaneous Drug Technology

Novartis has signed a landmark agreement with South Korean...
- Advertisement -

Teva Pharmaceutical Industries Ltd. announced that it has completed the acquisition of Theramex, Merck KGaA’s European-based women’s health business. 

Acquisition Provides Teva with a Strong Platform to Expand its Global Women’s Health Franchise

Theramex brings to Teva a broad portfolio of women’s health and gynecology products sold in over 50 countries, primarily France and Italy. Theramex’s pipeline includes NOMAC/E2, a new oral contraceptive based on natural estrogens, which has successfully completed phase III studies and was submitted for approval in Europe.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector
Subscribe for Free

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Previous article
Novartis drug Tasigna received approval from the European Commission
Next article
Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3

Related stories

Drug Research

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.
Drug Research

EMA Initiates Data Sharing Pilot for New Approach Methodologies

The European Medicines Agency has launched a voluntary framework for sharing data from non-animal testing methods to build regulatory confidence and refine drug development.
Business & Industry

Novartis Signs $3.22 Billion Deal with Alteogen for Subcutaneous Drug Technology

Novartis has signed a landmark agreement with South Korean...
News

How Prescription Medications Can Impair Driving Ability

Medication safety is not limited to achieving the intended...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

EMA Initiates Data Sharing Pilot for New Approach Methodologies

EMA Initiates Data Sharing Pilot for New Approach Methodologies